|
|
|
|
|
AMGen 
|
|
AMGen Incorporation is the global biotechnology enterprise which was established in the year 1980. The headquarters of AMGen Inc. are situated at the Newbury Park – the part of Thousand Oaks in California – the United States. The company is supposed to be the biggest autonomous biotechnology enterprise which employs around 15,000 people.
The term AMGen is the combination of the original name of the company which broadly denotes Applied Molecular Genetics which gradually became the formal name of the company during 1983 – precisely 3 years of the company’s incorporation as well as the first ever public offerings inadvertently.
AMGen is also reported to have strong history of taking over a few of the most leading corporate enterprises such as: Synergen Inc during 1994, Kinetix Pharmaceuticals Inc during 2000, Immunex Corporation during 2002, Tularik Inc during 2004, Abgenix Inc during 2006, Avidia Inc also during 2006, Ilypsa Inc and Alantos Pharmaceuticals Holdings Inc both during the current year i.e. 2007.
It is reported that for poising as the most future-oriented enterprise, Business Week has AMGen in the 4th position on the S&P 500 on the strength of ratio calculations made apparently on research and development expenses or budgets along with capital spending, and the total outlays by the contenders. AMGen showed the fourth highest ratio figuring as 506:1000. The company is also the member of the Pennsylvania Bio Commerce Organization.
The major products of AMGen include: Epogen, Aranesp, Enbrel, Kineret, Neulasta, Neupogen, Senispar and Mimpara of which Epogen and Neupogen were the first two biopharmaceutical products of the company when they were launched in the markets.
|
|
|
|
|
|
|
Biogan Idec
, Bosch and Lomb
, Eltana
, Tevaa Pharmaceutical Industries
, Tanaba Seiyaku co
, Johnsun and Johnsun
, Whyeth
, AstraZeneka
, Baayer
, Chiren Corporation
|
|
|
|
|
| Latest News About amgen |
|
|
|
IF that happens, Amgen will become the second biotechnology firm (Genentech.. Many analysts see now Amgen at - with six other drugs in clinical attempts, .....More |
|
|
|
|
On one GAAP basis, the certain costs, Amgen salaries does not consider, climbed 56 to 53... Amgen reported also third quarter Enbrel revenue of $342 million, .....More |
|
|
|
|
On the 22 January 1997, AMGEN has a declaratory judgment action against SCHERING and. abgelegt. On the 24 January 1997, AMGEN has on Scheringand process in that. geantwortet...More |
|
|
|
|
The Boston rehabilitation authority AMGEN Inc sent to help yesterday. its proposal... The AMGEN been based on California, the nationand most largely and most profitably.....More |
|
|
|
|
Meanwhile a group of the scientists that were released by AMGEN formed,... AMGEN expects to adjust at least 100 workers there through the end of this year, .....More |
|
|
|
|
THE share price of Amgen (expressed AM jen) climbed $6.75 today, TO $95,50,.. Amgen isolated THE gene for production of G-CSF and places it in bacteria, .....More |
|
|
|
|
Therefore itand time for us, something of Amgen gmbh to buying, (Nasdaq: AMGN). ... And now, Amgen. Is what this? are we, who find too many large firms in that of a share, .....More |
|
|
|
|
Amgen and Abgenix collaborated to develop a drug, called Panitumumab, gives full is ... the acquisition also Amgen a piping that of other promise.....More |
|
|
|
|
BOSTON Amgen, the worldand the largest biotechnology firm, Thursday said that... the agreement with Genentech, a rival, will give Amgen access to a sentence of.....More |
|
|
|
|
(Totally herein Amgen). the and837 patent a continuation of United States is be similar... in a prior process involving that parties in interest, formed Amgen, .....More |
|
|
|
|
|
|
|
